End Stage Renal Disease. Chronic kidney disease, stage 5
Conditions
Interventions
Intervention 1: Intervention group: In the intervention group, based on the volume recorded on the catheter, the required amounts of Ceftazidime 10 mg / ml (Exir Pharmaceutical Company, Borujerd, Iran
Sponsors
Sanandaj University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: All ?End Stage Renal Disease (ESRD) patients who are hemodialized using tunneled catheters .
Exclusion criteria
Exclusion criteria: Lack of patient collaboration Patients who use f tarolock solution Patients who are candidates for antibiotic prescription for any other reason .
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Nasal colonizing organism. Staphylococcus aureus. Timepoint: Monthly. Method of measurement: Antibiogram. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactNeshat Mohammadzadeh
Sanandaj University of Medical Sciences
Outcome results
None listed